Viewing Study NCT04905212


Ignite Creation Date: 2025-12-26 @ 11:12 PM
Ignite Modification Date: 2025-12-26 @ 11:12 PM
Study NCT ID: NCT04905212
Status: TERMINATED
Last Update Posted: 2023-12-06
First Post: 2021-05-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Telitacicept for Injection (RC18) in Subjects With IgA Nephropathy
Sponsor: RemeGen Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module